VERRICA PHARMACEUTICALS INC.

VRCA NASDAQ
9.19
+0.43
+4.91%
After Hours: 9.19 0 0.00% 17:00 08/16 EDT
Open
8.87
Prev Close
8.76
High
9.62
Low
8.72
Volume
22.37K
Avg Vol (3M)
48.92K
52 Week High
18.58
52 Week Low
6.44
% Turnover
0.09%
Market Cap
229.26M
1D
5D
1M
3M
1Y
5Y

Related

Webull offers VERRICA PHARMACEUTICALS INC. VRCA stock price, real time market quotes, professional analyst ratings, and in-depth charts, You can share investing ideas in community to communicate with others and learn trading skills.

Company Profile

Verrica Pharmaceuticals Inc. is a United States-based clinical-stage medical dermatology company. The Company is focused on identifying, developing and commercializing pharmaceutical products for the treatment of skin diseases with unmet needs. Its lead product candidate, VP-102, is a drug-device combination of topical solution of cantharidin. The Company also intends to develop second cantharidin-based product candidate, VP-103, for the treatment of plantar warts. The Company has completed one Phase II clinical trial of topical solution of cantharidin administered with the wooden stick part of a cotton-tipped swab. It also conducting another Phase II clinical trial of topical solution of cantharidin administered through applicator, which collectively refer to as VP-102, for the treatment of molluscum.
MORE >

Recently

Name
Price
%Change